Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer

Journal of Experimental and Clinical Cancer Research

Volumn 33, Issue 1, 2014, Pages

  Kanda, Mitsuro ^a   Nomoto, Shuji ^a   Oya, Hisaharu ^a   Hashimoto, Ryoji ^a   Takami, Hideki ^a   Shimizu, Dai ^a   Sonohara, Fuminori ^a   Kobayashi, Daisuke ^a   Tanaka, Chie ^a   Yamada, Suguru ^a   Fujii, Tsutomu ^a   Nakayama, Goro ^a   Sugimoto, Hiroyuki ^a   Koike, Masahiko ^a   Murotani, Kenta ^b   Fujiwara, Michitaka ^a   Kodera, Yasuhiro ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Expression; Gastric cancer; Methylation; Prenyl diphosphate synthase subunit 2; Subtype

Indexed keywords

CA 19-9 ANTIGEN; MESSENGER RNA; PRENYL DIPHOSPHATE SYNTHASE SUBUNIT 2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 2, HUMAN; TRANSFERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; RECURRENCE FREE SURVIVAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; VERY ELDERLY; CHI SQUARE DISTRIBUTION; DISEASE FREE SURVIVAL; DOWN REGULATION; ENZYMOLOGY; GASTRECTOMY; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STOMACH NEOPLASMS; TIME; TREATMENT OUTCOME; TUMOR CELL LINE; TUMOR RECURRENCE; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALKYL AND ARYL TRANSFERASES; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CHI-SQUARE DISTRIBUTION; CPG ISLANDS; DISEASE-FREE SURVIVAL; DNA METHYLATION; DOWN-REGULATION; FEMALE; GASTRECTOMY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; RNA, MESSENGER; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84965190202     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-014-0088-3     Document Type: Article

References (34)

1. Wang Z, Wang J, Yang Y, Hao B, Wang R, Li Y, Wu Q: Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer. J Exp Clin Cancer Res 2013, 32:76.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
3. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, Gotoda T, Lin JT, You WC, Ng EK, Sung JJ: Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008, 9:279-287.
4. Kanda M, Nomoto S, Oya H, Shimizu D, Takami H, Hibino S, Hashimoto R, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y: Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer. J Exp Clin Cancer Res 2014, 33:66.
5. Wang YY, Li L, Zhao ZS, Wang YX, Ye ZY, Tao HQ: Li and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients. J Exp Clin Cancer Res 2013, 32:66.
6. Resende C, Thiel A, Machado JC, Ristimaki A: Gastric cancer: basic aspects. Helicobacter 2011, 16(Suppl 1):38-44.
7. Kanda M, Shimizu D, Nomoto S, Takami H, Hibino S, Oya H, Hashimoto R, Suenaga M, Inokawa Y, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y: Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer. Gastric Cancer 2014, Epub ahead of print, PubMed PMID: 24695972.
8. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965, 64:31-49.
9. Shah MA, Khanin R, Tang L, Janjigian YY, Klimstra DS, Gerdes H, Kelsen DP: Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res 2011, 17:2693-2701.
10. Saiki R, Nagata A, Kainou T, Matsuda H, Kawamukai M: Characterization of solanesyl and decaprenyl diphosphate synthases in mice and humans. Febs j 2005, 272:5606-5622.
11. Chen P, Yu J, Knecht J, Chen Q: Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer. Cancer Epidemiol 2013, 37:166-171.
12. Fung JM, Smith R, Brown MA, Lau SH, Xie D, Lau GK, Guan XY: Identification and characterization of a novel melanoma tumor suppressor gene on human chromosome 6q21. Clin Cancer Res 2009, 15:797-803.
13. Quinzii CM, DiMauro S, Hirano M: Human coenzyme Q10 deficiency. Neurochem Res 2007, 32:723-727.
14. DiMauro S, Quinzii CM, Hirano M: Mutations in coenzyme Q10 biosynthetic genes. J Clin Invest 2007, 117:587-589.
15. Turunen M, Olsson J, Dallner G: Metabolism and function of coenzyme Q. Biochim Biophys Acta 2004, 1660:171-199.
16. Li BC, Chan WY, Li CY, Chow C, Ng EK, Chung SC: Allelic loss of chromosome 6q in gastric carcinoma. Diagn Mol Pathol 2003, 12:193-200.
17. Carvalho B, Seruca R, Carneiro F, Buys CH, Kok K: Substantial reduction of the gastric carcinoma critical region at 6q16.3-q23.1. Genes Chromosomes Cancer 1999, 26:29-34.
18. Chen P, Zhao SH, Chu YL, Xu K, Zhu L, Wu Y, Song J, Cao CX, Xue X, Niu YY: Anticancer activity of PDSS2, prenyl diphosphate synthase, subunit 2, in gastric cancer tissue and the SGC7901 cell line. Anticancer Drugs 2009, 20:141-148.
19. Sobin LH, Gospodarowicz MK, C W: International Union Against Cancer, TNM Classification of Malignant Tumors. 7th edition. New York: Wiley-Blackwell; 2009.
20. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007, 357:1810-1820.
21. Kanda M, Nomoto S, Oya H, Takami H, Hibino S, Hishida M, Suenaga M, Yamada S, Inokawa Y, Nishikawa Y, Asai M, Fujii T, Sugimoto H, Kodera Y: Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma. Int J Oncol 2014, 44:44-52.
22. Kanda M, Nomoto S, Okamura Y, Nishikawa Y, Sugimoto H, Kanazumi N, Takeda S, Nakao A: Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis. Int J Oncol 2009, 35:477-483.
23. Kanda M, Shimizu D, Nomoto S, Hibino S, Oya H, Takami H, Kobayashi D, Yamada S, Inokawa Y, Tanaka C, Fujii T, Sugimoto H, Koike M, Fujiwara M, Kodera Y: Clinical significance of expression and epigenetic profiling of TUSC1 in gastric cancer. J Surg Oncol 2014, 110:136-144.
24. Takai D, Jones PA: The CpG island searcher: a new WWW resource. In Silico Biol 2003, 3:235-240.
25. Kanda M, Nomoto S, Okamura Y, Hayashi M, Hishida M, Fujii T, Nishikawa Y, Sugimoto H, Takeda S, Nakao A: Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma. Mol Carcinog 2011, 50:571-579.
26. Queimado L, Seruca R, Costa-Pereira A, Castedo S: Identification of two distinct regions of deletion at 6q in gastric carcinoma. Genes Chromosomes Cancer 1995, 14:28-34.
27. Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A: Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997, 14:2927-2933.
28. Chen P, Zhang Y, Polireddy K, Chen Q: The tumor-suppressing activity of the prenyl diphosphate synthase subunit 2 gene in lung cancer cells. Anticancer Drugs 2014, 25:790-798.
29. An JH, Kim JW, Jang SM, Kim CH, Kang EJ, Choi KH: Gelsolin negatively regulates the activity of tumor suppressor p53 through their physical interaction in hepatocarcinoma HepG2 cells. Biochem Biophys Res Commun 2011, 412:44-49.
30. Jang BG, Kim WH: Molecular pathology of gastric carcinoma. Pathobiology 2011, 78:302-310.
31. Kim TY, Jong HS, Jung Y, Kim TY, Kang GH, Bang YJ: DNA hypermethylation in gastric cancer. Aliment Pharmacol Ther 2004, 20(Suppl 1):131-142.
32. To KF, Leung WK, Lee TL, Yu J, Tong JH, Chan MW, Ng EK, Chung SC, Sung JJ: Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 2002, 102:623-628.
33. Janjigian YY, Kelsen DP: Genomic dysregulation in gastric tumors. J Surg Oncol 2013, 107:237-242.
34. Bird A: Perceptions of epigenetics. Nature 2007, 447:396-398.